Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 140 articles:
HTML format



Single Articles


    November 2022
  1. MOUSSAVI Z
    Repetitive TMS applied to the precuneus stabilizes cognitive status in Alzheimer's disease.
    Brain. 2022;145:3730-3732.
    PubMed    


  2. OBERSTEIN TJ, Schmidt MA, Florvaag A, Haas AL, et al
    Amyloid-beta levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.
    Brain. 2022;145:4032-4041.
    PubMed     Abstract available


  3. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    PubMed     Abstract available


  4. HUGHES TM, Craft S
    Cerebral insulin receptors: a nexus for vascular and metabolic contributions to Alzheimer's disease.
    Brain. 2022 Nov 19:awac433. doi: 10.1093.
    PubMed    


    October 2022
  5. SEYEDSALEHI A, Warrier V, Bethlehem RAI, Perry BI, et al
    Educational attainment, structural brain reserve and Alzheimer's disease: a Mendelian randomization analysis.
    Brain. 2022 Oct 31. pii: 6780317. doi: 10.1093.
    PubMed     Abstract available


  6. NEMY M, Dyrba M, Brosseron F, Buerger K, et al
    Cholinergic white matter pathways along the Alzheimer's disease continuum.
    Brain. 2022 Oct 26. pii: 6775152. doi: 10.1093.
    PubMed     Abstract available


  7. KOCH G, Casula EP, Bonni S, Borghi I, et al
    Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.
    Brain. 2022 Oct 25. pii: 6701823. doi: 10.1093.
    PubMed     Abstract available


  8. LECLERC M, Bourassa P, Tremblay C, Caron V, et al
    Cerebrovascular insulin receptors are defective in Alzheimer's disease.
    Brain. 2022 Oct 25. pii: 6761474. doi: 10.1093.
    PubMed     Abstract available


  9. LI X, Ospitalieri S, Robberechts T, Hofmann L, et al
    Seeding, maturation and propagation of amyloid beta-peptide aggregates in Alzheimer's disease.
    Brain. 2022;145:3558-3570.
    PubMed     Abstract available


  10. SINGLETON EH, Fieldhouse JLP, van 't Hooft JJ, Scarioni M, et al
    Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease.
    Brain. 2022 Oct 21. pii: 6765142. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  11. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    PubMed     Abstract available


  12. JANELIDZE S, Bali D, Ashton NJ, Barthelemy NR, et al
    Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Brain. 2022 Sep 10. pii: 6695388. doi: 10.1093.
    PubMed     Abstract available


  13. BUCKLEY R
    Sex differences in Alzheimer's disease risk: are immune responses the key?
    Brain. 2022 Sep 2. pii: 6686583. doi: 10.1093.
    PubMed    


    August 2022
  14. RABIN JS, Nichols E, La Joie R, Casaletto KB, et al
    Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
    Brain. 2022;145:2823-2833.
    PubMed     Abstract available


  15. SNELLMAN A, Lantero-Rodriguez J, Emersic A, Vrillon A, et al
    N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
    Brain. 2022;145:2834-2848.
    PubMed     Abstract available


  16. RIKU Y, Iwasaki Y, Ishigaki S, Akagi A, et al
    Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Brain. 2022;145:2769-2784.
    PubMed     Abstract available


  17. SAPKOTA D, Florian C, Doherty BM, White KM, et al
    Aqp4 stop codon readthrough facilitates amyloid-beta clearance from the brain.
    Brain. 2022 Aug 24. pii: 6671408. doi: 10.1093.
    PubMed     Abstract available


  18. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    PubMed     Abstract available


  19. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
    Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
    PubMed     Abstract available


  20. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  21. HUSAIN M
    Molecular pathology and biomarker of progression in Alzheimer's disease.
    Brain. 2022;145:2229-2230.
    PubMed    


  22. GROOT C, Holstege H, Ossenkoppele R
    Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
    Brain. 2022;145:2239-2241.
    PubMed    


  23. CASALETTO KB, Nichols E, Aslanyan V, Simone SM, et al
    Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
    Brain. 2022 Jul 23. pii: 6648895. doi: 10.1093.
    PubMed     Abstract available


  24. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    PubMed     Abstract available


  25. DEWENTER A, Jacob MA, Cai M, Gesierich B, et al
    Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
    Brain. 2022 Jul 21. pii: 6647593. doi: 10.1093.
    PubMed     Abstract available


  26. BIESSELS GJ
    Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?
    Brain. 2022 Jul 15. pii: 6644842. doi: 10.1093.
    PubMed    


  27. WANG Q, Huang X, Su Y, Yin G, et al
    Activation of Wnt/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Brain. 2022 Jul 5. pii: 6630034. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  28. GRAHAM NSN
    Progress towards predicting neurodegeneration and dementia after traumatic brain injury.
    Brain. 2022;145:1874-1876.
    PubMed    


  29. JENKINS LM, Wang L, Rosen H, Weintraub S, et al
    A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia.
    Brain. 2022;145:1886-1905.
    PubMed     Abstract available


  30. MEHRARAM R, Peraza LR, Murphy NRE, Cromarty RA, et al
    Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.
    Brain. 2022;145:2190-2205.
    PubMed     Abstract available


  31. LEVEY AI, Qiu D, Zhao L, Hu WT, et al
    A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
    Brain. 2022;145:1924-1938.
    PubMed     Abstract available


  32. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    PubMed     Abstract available


  33. KAIVOLA K, Shah Z, Chia R, Scholz SW, et al
    Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
    Brain. 2022;145:1757-1762.
    PubMed     Abstract available


    May 2022
  34. TONIOLO S
    What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
    Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
    PubMed    


  35. DUZEL E, Ziegler G, Berron D, Maass A, et al
    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
    Brain. 2022;145:1473-1485.
    PubMed     Abstract available


  36. KO H, Kim S, Kim K, Jung SH, et al
    Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
    Brain. 2022;145:1436-1448.
    PubMed     Abstract available


  37. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
    Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
    Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
    PubMed     Abstract available


  38. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
    Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
    PubMed     Abstract available



  39. Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
    PubMed    


  40. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    PubMed     Abstract available


  41. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
    Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
    PubMed     Abstract available


  42. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
    Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
    Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  43. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
    Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
    Brain. 2022;145:1079-1097.
    PubMed     Abstract available


  44. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Brain. 2022;145:1052-1068.
    PubMed     Abstract available


  45. MESULAM MM, Coventry CA, Bigio EH, Sridhar J, et al
    Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Brain. 2022 Apr 20. pii: 6570516. doi: 10.1093.
    PubMed     Abstract available


  46. SHAHID SS, Wen Q, Risacher SL, Farlow MR, et al
    Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
    Brain. 2022 Apr 12. pii: 6566798. doi: 10.1093.
    PubMed     Abstract available


  47. OLIVEROS G, Wallace CH, Chaudry O, Liu Q, et al
    Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
    Brain. 2022 Apr 12. pii: 6566790. doi: 10.1093.
    PubMed     Abstract available


  48. STEVENSON-HOARE J, Heslegrave A, Leonenko G, Fathalla D, et al
    Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Brain. 2022 Apr 6. pii: 6564132. doi: 10.1093.
    PubMed     Abstract available


  49. PADHI S, Sarangi S, Nayak N, Pati A, et al
    OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
    Brain. 2022 Apr 6. pii: 6564066. doi: 10.1093.
    PubMed    


    March 2022
  50. JEONG YY, Han S, Jia N, Zhang M, et al
    Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.
    Brain. 2022;145:305-323.
    PubMed     Abstract available


  51. BENATAR M, Wuu J, McHutchison C, Postuma RB, et al
    Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Brain. 2022;145:27-44.
    PubMed     Abstract available


  52. HOSOKAWA M, Masuda-Suzukake M, Shitara H, Shimozawa A, et al
    Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Brain. 2022;145:349-361.
    PubMed     Abstract available


  53. GIACOBINI E, Cuello AC, Fisher A
    Reimagining cholinergic therapy for Alzheimer's disease.
    Brain. 2022 Mar 15. pii: 6548684. doi: 10.1093.
    PubMed     Abstract available


  54. SHETTY AK
    Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
    Brain. 2022 Mar 12. pii: 6547363. doi: 10.1093.
    PubMed    


  55. LAM AD, Shafi MM
    Towards a coherent view of network hyperexcitability in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6544859. doi: 10.1093.
    PubMed    


  56. LIN CP, Frigerio I, Boon BDC, Zhou Z, et al
    Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6543231. doi: 10.1093.
    PubMed     Abstract available


  57. GABRIELLI M, Prada I, Joshi P, Falcicchia C, et al
    Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
    Brain. 2022 Mar 3. pii: 6541881. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  58. BEAMAN EE, Bonde AN, Ulv Larsen SM, Ozenne B, et al
    Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension.
    Brain. 2022 Feb 23. pii: 6535129. doi: 10.1093.
    PubMed     Abstract available


  59. PERIS L, Parato J, Qu X, Soleilhac JM, et al
    Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.
    Brain. 2022 Feb 11. pii: 6527175. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  60. KARANTH SD, Katsumata Y, Nelson PT, Fardo DW, et al
    Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Brain. 2022 Jan 30. pii: 6517521. doi: 10.1093.
    PubMed     Abstract available


  61. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available


  62. MARTINO ADAMI PV, Orellana A, Garcia P, Kleineidam L, et al
    Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
    Brain. 2022 Jan 28. pii: 6516341. doi: 10.1093.
    PubMed     Abstract available


  63. STERN AM, Liu L, Jin S, Liu W, et al
    A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain.
    Brain. 2022 Jan 27. pii: 6516009. doi: 10.1093.
    PubMed     Abstract available


  64. ALI M, Falkenhain K, Njiru BN, Murtaza-Ali M, et al
    VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.
    Brain. 2022 Jan 20. pii: 6512043. doi: 10.1093.
    PubMed     Abstract available


  65. BRIDEL C, Somers C, Sieben A, Rozemuller A, et al
    Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Brain. 2022 Jan 13. pii: 6506576. doi: 10.1093.
    PubMed     Abstract available


  66. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  67. LEE Y, Miller MR, Fernandez MA, Berg EL, et al
    Early lysosome defects precede neurodegeneration with amyloid-beta and tau aggregation in NHE6-null rat brain.
    Brain. 2021 Dec 20. pii: 6470622. doi: 10.1093.
    PubMed     Abstract available


  68. RANASINGHE KG, Kudo K, Hinkley L, Beagle A, et al
    Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease.
    Brain. 2021 Dec 17. pii: 6469013. doi: 10.1093.
    PubMed     Abstract available


  69. XHIMA K, Markham-Coultes K, Kofoed RH, Saragovi HU, et al
    Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
    Brain. 2021 Dec 17. pii: 6469023. doi: 10.1093.
    PubMed     Abstract available


  70. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available


  71. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available


  72. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  73. VERDI S, Marquand AF, Schott JM, Cole JH, et al
    Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
    Brain. 2021;144:2946-2953.
    PubMed     Abstract available


    October 2021
  74. ZHANG Y, Zhang Y, Aman Y, Ng CT, et al
    Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
    Brain. 2021;144:2759-2770.
    PubMed     Abstract available


  75. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
    Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
    Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
    PubMed     Abstract available


  76. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available


  77. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
    A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
    PubMed     Abstract available


  78. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available


  79. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
    Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
    PubMed     Abstract available


    September 2021

  80. Erratum to: Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Sep 22. pii: 6373794. doi: 10.1093.
    PubMed    


  81. STOTHART G, Smith LJ, Milton A, Coulthard E, et al
    A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.
    Brain. 2021 Sep 20. pii: 6372384. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  82. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    PubMed    


  83. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    PubMed     Abstract available


  84. BOYLE PA, Wang T, Yu L, Wilson RS, et al
    To what degree is late life cognitive decline driven by age-related neuropathologies?
    Brain. 2021;144:2166-2175.
    PubMed     Abstract available


  85. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available


  86. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  87. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    PubMed     Abstract available


  88. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    PubMed     Abstract available


  89. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    PubMed    


  90. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available


  91. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    PubMed    


  92. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
    PubMed    


    June 2021
  93. RIES M, Watts H, Mota BC, Lopez MY, et al
    Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology.
    Brain. 2021;144:1526-1541.
    PubMed     Abstract available


  94. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
    Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
    PubMed     Abstract available


  95. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    PubMed     Abstract available


  96. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available


    May 2021

  97. Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
    PubMed    


  98. DEHGHANI N, Bras J, Guerreiro R
    Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
    PubMed    


    April 2021
  99. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    PubMed     Abstract available


  100. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    PubMed     Abstract available


  101. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    PubMed     Abstract available



  102. Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    PubMed    


  103. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    PubMed     Abstract available


  104. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.
    PubMed    



  105. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    PubMed    


    March 2021
  106. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    PubMed     Abstract available


  107. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    PubMed     Abstract available


  108. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available


  109. ASBY D, Boche D, Allan S, Love S, et al
    Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
    PubMed     Abstract available


  110. SPINA S, La Joie R, Petersen C, Nolan AL, et al
    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
    PubMed     Abstract available


  111. HUSAIN M
    Blood tests to screen for Alzheimer's disease.
    Brain. 2021;144:355-356.
    PubMed    


  112. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    PubMed     Abstract available


    February 2021
  113. JAGUST W
    Integrating events in the disintegration of Alzheimer's disease.
    Brain. 2021;144:11-14.
    PubMed    


  114. TIJMS BM, Teunissen CE
    Concatenating plasma p-tau to Alzheimer's disease.
    Brain. 2021;144:14-17.
    PubMed    


    January 2021
  115. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
    Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
    PubMed     Abstract available



  116. Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
    PubMed    


    December 2020
  117. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    PubMed     Abstract available


  118. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
    Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
    PubMed     Abstract available


  119. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
    PubMed     Abstract available


  120. TEUNISSEN CE, Thijssen EH, Verberk IMW
    Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
    Brain. 2020;143:3170-3172.
    PubMed    


  121. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available


  122. TIJMS BM, Gobom J, Reus L, Jansen I, et al
    Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Brain. 2020;143:3776-3792.
    PubMed     Abstract available


  123. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
    The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Brain. 2020;143:3805-3815.
    PubMed     Abstract available


  124. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
    Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Brain. 2020;143:3653-3671.
    PubMed     Abstract available


    November 2020
  125. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available


  126. BRIER MR, Day GS
    Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
    PubMed    


  127. SUR C, Kost J, Scott D, Adamczuk K, et al
    BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
    PubMed     Abstract available


  128. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
    Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
    PubMed     Abstract available


  129. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
    Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
    PubMed     Abstract available


  130. JIA L, Li F, Wei C, Zhu M, et al
    Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
    PubMed     Abstract available


  131. LIU KY, Reeves S, McAleese KE, Attems J, et al
    Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
    PubMed     Abstract available


  132. JI X, Liu G
    rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
    PubMed    


  133. DUMITRESCU L, Hohman TJ
    Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
    PubMed    


  134. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
    Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
    PubMed     Abstract available


  135. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
    18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  136. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
    Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  137. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
    Impairments of auditory scene analysis in posterior cortical atrophy.
    Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  138. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
    18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  139. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
    Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Brain. 2020;143:1889-1904.
    PubMed     Abstract available


    January 2020
  140. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
    The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: